by Michael J. Shapiro | January 01, 2010
A steadily growing number of regulations and recommendations can affect medical and pharmaceutical meetings. Among them:

• Pharmaceutical Research and Manufacturers of America (PhRMA), which issues its Code on Interactions with Healthcare Professionals

• Advanced Medical Technology Association (AdvaMed), which issues its Code of Ethics on Interactions with Health Care Professionals

• The Office of Inspector General, which issues the Compliance Program Guidance for Pharmaceutical Manufacturers

• The federal U.S. Food and Drug Administration, which issues guidance, compliance and regulation materials

• The Foreign Corrupt Practices Act (the involvement of governments in foreign health care systems make international business susceptible to bribes and corruption)

• The Physician Payments Sunshine Act (federal legislation that is yet to be passed but which will require much greater transparency regarding doctor payments or gifts of any sort, including meals and compensation for speaking engagements)

• State laws (strict legislation, such as that passed in Massachusetts and Vermont, regarding interaction with health care professionals; laws apply to interactions with doctors who practice in the states in question, and fines and penalties may be levied for noncompliance).